InvestorsHub Logo
Followers 4
Posts 1510
Boards Moderated 0
Alias Born 08/23/2010

Re: None

Sunday, 08/30/2015 1:08:06 AM

Sunday, August 30, 2015 1:08:06 AM

Post# of 13735
May-June 2007 issue of Diabetes Hoy (publication of Mexican Diabetes Federation for doctors and other health professionals) contained a review of Sucanon and a discussion of metformin and insulin sensitizers for any that care to google it. Interestingly, that endorsement came when Sucanon was owned and produced by Biotech holdings. Before Fero bought the assets from the now deceased Biotech holdings owners family. In fact before any of the concerns now raised about shell companies, scams, or objectivity of Dr Jiminez and his Sucanon study presentation at EASD. The studies and data on efficacy has been out there a long time and is there for any who wish to do DD on Sucanon. IMO based on the science and the study results Sucanons efficacy is not what has held this company back. The marketing to get the information out to those who need it to make the product successful has not been effective or consistent. If that can be solved, ROTH could be very successful with Sucanon. That is why I am an investor.